Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells
Patent Number: 6261841
Date of First Priority Issue: Friday June 25th, 1999
Date Issued: Tuesday July 17th, 2001
Assignee: The Board of Trustees of Northwestern University (Evanston, IL)
Inventors: Cohen, Isaac (Wilmette, IL); Lefebvre, Phil (Chicago, IL); Lin, Jiandie (Evanston, IL); Linzer, Daniel (Evanston, IL)
From Class: Differentiation
Comments: No comments
This patent teaches that administration of prolactin may be used for enhancing hematopoiesis. This is interesting since there are other patents, including by Stem Cell Therapeutics, that teach the use of prolactin and other compounds for stimulation of neural stem cells.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.